In this minisode, Mindy, Ryan, and Jen discuss a few recent newsworthy items including: the latest in COVID-19 vaccines and treatments (00:34), updates on Pfizer’s copay assistance legal battle (03:55) and surprise billing arbitration (06:30), and the start of Medicare Advantage & Part D open enrollment (10:42).
Building an Industry-Changing Patient Innovation Hub
Only 10% of pharma’s patient programmes measure the patient experience. To address this gap, a leading global pharmaceutical company engaged Vynamic as a strategic partner to establish a Patient Innovation Hub that will help change the way the industry develops patient-focused solutions in the future.
Developing a Diversity, Equity, & Inclusion Roadmap and Company Mindset
The leadership of a large global pharmaceutical company placed a priority focus on Diversity, Equity, & Inclusion (DEI) and engaged Vynamic to help define and mobilize a roadmap of initiatives with the intention of embedding more holistic DEI thinking within the organization. Read how Vynamic helped instill accountability among the company leadership to ensure DEI would have a long-lasting impact on employees.
The recent proliferation and adoption of digital health technologies is often heralded as a key mechanism in closing the gap when it comes to health disparities. In this episode, Jen and Mindy are joined by special guest DJ O’Connor to discuss equality barriers in digital health and how healthcare leaders can develop more equitable solutions. …
In this minisode, Mindy, Ryan, and Jen discuss a few recent newsworthy items including: the Supreme Court’s decision to deny an emergency appeal to block enforcement of a controversial Texas abortion law (00:35), a recent report on Medicare hospital fund insolvency (03:25), and an FDA committee meeting on complex gene therapy safety questions (11:11). …
Opportunities for Patient Centricity in Life Sciences
September 2, 2021
Patient centricity is no longer a buzzword, it’s redefining how the pharmaceutical industry operates to deliver the best outcomes and experiences for patients. In this episode, Jen is joined by Vynamic London team members Gemma Pfister and Jack Young to discuss opportunities to become more patient centric throughout the medicine development lifecycle. Inclusiveness, empowerment, and …
In this minisode, Mindy, Ryan, and Jen discuss a few recent newsworthy items including: the impact of the Delta variant on the healthcare system (00:31), a crackdown on “pay for delay” in the generic space (05:53), and the fight to legalize Medicare copay assistance (09:25). Podcast Tags: COVID-19, vaccination, drug prices, generics, biosimilars, Medicare, copays, …
Importance of Culture in Return to Workplace Planning
August 5, 2021
Climbing COVID-19 vaccination rates have enabled many countries to relax social distancing requirements and business leaders to implement their return to workplace plans. In this episode, Ryan and Jen are joined by Vynamic’s Lauren Scandone and Stefanie Christmas to discuss the importance of culture in developing and executing those plans. The past eighteen months have …
COVID-19 Business Response – Phase 4: The Great Culture Reset
The COVID-19 vaccine roll-out is well underway, and with full re-openings and talk of “return to normal”, many business leaders are finalizing or implementing return to workplace plans. While many organizations may have already put significant thought into safely re-opening physical workplaces, there are additional complexities that should be considered that could have far greater …
In this minisode, Mindy, Ryan, and Jen discuss a few recent newsworthy items including: the Biden administration’s interim final rule banning surprise billing (00:35), Walmart’s launch of a private band insulin analog (04:21), and interim trial results for in vivo CRISPR-based genome editing candidate NTLA-2001 (07:00). Podcast Tags: surprise billing, health insurance, diabetes, drug prices, …
